A Study to Evaluate the 17-Year Immune Persistence of a Single Dose of Inactivated Hepatitis A Vaccine

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this follow-up study is to evaluate the seventeen-year immune persistence of a single dose of inactivated or attenuated alive hepatitis A vaccine in healthy participants.
Epistemonikos ID: dde129f91d84db8e610e2ecf20dbf71bf1c05559
First added on: Oct 03, 2026